Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)

Market Cap	7.18B -2.2%
Revenue (ttm)	1.19B -4.2%
Net Income	258.62M -17.7%
EPS	0.43 -21.4%
Shares Out	543.69M
PE Ratio	30.82
Forward PE	16.51
Dividend	0.11 (0.86%)
Ex-Dividend Date	Apr 30, 2025

Volume	7,446,326
Average Volume	11,633,221
Open	13.28
Previous Close	13.15
Day's Range	13.06 - 13.28
52-Week Range	12.99 - 19.67
Beta	0.60
RSI	36.47
Earnings Date	Apr 18, 2026

About SHE:300401

Zhejiang Garden Biopharmaceutical Co.,Ltd. engages in the research, development, production and sales of vitamin products and pharmaceuticals in China. The company offers lanolin cholesterol series products, such as cholesterol and feed grade cholesterol; vitamin D3 products, including food additives compound nutrient fortifier SDS, food additives compound nutritional fortifier CO and MO, cholecalciferol, vitamin D3 particles, feed additive vitamin D3 oil, and VD3 resin oil; and 25 HydroxyVitamin D3 Progen, 25 hydroxyvitamin D3, and 25 hydroxyv...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 1,021
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300401

Financial Performance

In 2025, SHE:300401's revenue was 1.24 billion, a decrease of -0.47% compared to the previous year's 1.24 billion. Earnings were 304.86 million, a decrease of -1.41%.